Brief: China Resources Pharmaceutical Posts FY Net Profit Attributable Of CR Boya Bio-Pharmaceutical Of RMB397 Million
March 18 (Reuters) - China Resources Boya Bio pharmaceutical Group Co Ltd 300294.SZ: FY NET PROFIT ATTRIBUTABLE OF CR BOYA BIO-PHARMACEUTICAL RMB397 MILLION FY REVENUE FOR CR BOYA BIO-PHARMACEUTICAL RMB1.73 BILLION Further company coverage: 300294.SZ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Says KPC Pharmaceuticals Reports Nine Month Results
Brief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals